Benfotiamine, a vitamin B1 derivative, inhibits VEGF-induced angiogenesis.

Authors

Kieran V. Allowitz, Noorda College of Osteopathic MedicineFollow
Trevor J. Plowman, Noorda College of Osteopathic MedicineFollow
Kota Ramana, Noorda College of Osteopathic medicineFollow

Description

A in-vitro study that indicates that benfotiamine, a vitamin B1 derivative, has anti-angiogenic potential via the inhibition of various pro-angiogenic growth factors and promoting anti-angiogenic factors.

Document Type

Event

Recommended Citation

Allowitz, Kieran V.; Plowman, Trevor J.; and Ramana, Kota, "Benfotiamine, a vitamin B1 derivative, inhibits VEGF-induced angiogenesis." (2023). Annual Research Symposium. 1.
https://ecommons.roseman.edu/researchsymposium/2023/postergroup6/1